Oncolytics Biotech® Reports 2021 Second Quarter Development Highlights and Financial Results

Go back to Oncolytics Biotech® Reports 2021 Second Quarter Development Highlights and Financial Results

Oncolytics Biotech (ONCY) Reports Q2 Loss of $0.13/sh

August 6, 2021 7:43 AM EDT

Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.13), versus ($0.17) reported last year.

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

... More